Physician profile
Michael Lao
NPI 1164861969
$1,833.90
in general payments reported to CMS, 2019-2025
19 companies · $38.21 in 2025
The $38.21 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $294 · 2021: $828 · 2022: $265 · 2024: $157 · 2025: $38.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,036.90 | 2020-2024 | |
| Axonics, INC. | $183.35 | 2022 | |
| Abbvie INC. | $129.59 | 2024 | |
| Cook Medical LLC | $81.38 | 2022 | |
| Janssen Biotech, INC. | $55.76 | 2019-2020 | |
| Amgen INC. | $54.99 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $48.31 | 2019 | |
| Boston Scientific Corporation | $31.99 | 2021-2025 | Ams 700 |
| Glaxosmithkline, LLC. | $25.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.15 | 2019 | |
| Olympus Corporation of The Americas | $20.96 | 2019 | |
| Clovis Oncology, INC. | $19.06 | 2019 | |
| Puma Biotechnology, INC. | $18.72 | 2020 | |
| Eisai INC. | $18.14 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $17.72 | 2019 | |
| Procept Biorobotics Corporation | $17.33 | 2025 | |
| Sagent Pharmaceuticals | $15.06 | 2020 | |
| Tesaro, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.